{"entity":{"type":"insider","cik":"0001578823","url":"/insider/0001578823","json_url":"/insider/0001578823.json","name":"Sullivan Ryan T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2013-07-02","last":"2019-11-19","span_basis":"filed_date"},"name_variants":[{"name":"Sullivan Ryan T","source":"filing","n_filings":7,"first_seen":"2013-07-02","last_seen":"2019-11-19"}],"transactions":[{"id":7860872,"accession":"0001104659-19-065554","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-065554","line_url":"/filing/0001104659-19-065554","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12154.0,"shares_display":"12,154","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":1033090.0,"total_display":"1,033,090.00","total_whole":"1,033,090","shares_owned_after":25718.0,"shares_owned_after_display":"25,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-19","scope":"insider","n_lines":2},{"id":8310359,"accession":"0001104659-19-064832","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-064832","line_url":"/filing/0001104659-19-064832#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":42500.0,"total_display":"42,500.00","total_whole":"42,500","shares_owned_after":26429.0,"shares_owned_after_display":"26,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-15","scope":"insider"},{"id":2592425,"accession":"0001209191-16-116574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-116574","line_url":"/filing/0001209191-16-116574#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3125.0,"shares_display":"3,125","price_per_share":66.33,"price_display":"66.33","price_state":"stated","total_value":207281.25,"total_display":"207,281.25","total_whole":"207,281","shares_owned_after":30132.0,"shares_owned_after_display":"30,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-29","filed_date":"2016-04-29","scope":"insider"},{"id":2873548,"accession":"0001209191-16-089485","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-089485","line_url":"/filing/0001209191-16-089485","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (Sr. VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":111.78097025920873,"price_display":"111.78","price_state":"stated","total_value":81935.4512,"total_display":"81,935.45","total_whole":"81,935","shares_owned_after":27207.0,"shares_owned_after_display":"27,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-05","scope":"insider","n_lines":3},{"id":8887663,"accession":"0001209191-15-084826","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-084826","line_url":"/filing/0001209191-15-084826","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (Sr. VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":110.410497,"price_display":"110.41","price_state":"stated","total_value":1104104.97,"total_display":"1,104,104.97","total_whole":"1,104,105","shares_owned_after":31740.0,"shares_owned_after_display":"31,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-11","scope":"insider","n_lines":3},{"id":8489433,"accession":"0001209191-15-038038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-038038","line_url":"/filing/0001209191-15-038038#line-1","is_derivative":false,"issuer_cik":"0001411158","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001411158","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (Sr. VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (Sr. VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3125.0,"shares_display":"3,125","price_per_share":53.61,"price_display":"53.61","price_state":"stated","total_value":167531.25,"total_display":"167,531.25","total_whole":"167,531","shares_owned_after":27740.0,"shares_owned_after_display":"27,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-29","filed_date":"2015-05-01","scope":"insider"},{"id":4284860,"accession":"0001181431-13-038164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-038164","line_url":"/filing/0001181431-13-038164#line-1","is_derivative":false,"issuer_cik":"0001323854","issuer_name":"Warner Chilcott plc","issuer_ticker":"WCRX","issuer_name_source":null,"issuer_url":"/issuer/0001323854","owner_cik":"0001578823","owner_name":"Sullivan Ryan T","owner_display_name":"Sullivan Ryan T","owner_url":"/insider/0001578823","role":"Officer (VP, General Counsel & Secr)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel & Secr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel & Secr.","security_title":"Ordinary shares, par value $0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":169.0,"shares_display":"169","price_per_share":19.88,"price_display":"19.88","price_state":"stated","total_value":3359.72,"total_display":"3,359.72","total_whole":"3,360","shares_owned_after":26460.0,"shares_owned_after_display":"26,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Officer (General Counsel and Secretary)","n_filings":2,"first_seen":"2019-11-15","last_seen":"2019-11-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Officer (EVP and General Counsel)","n_filings":4,"first_seen":"2015-05-01","last_seen":"2016-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001323854","name":"Warner Chilcott plc","url":"/issuer/0001323854","role":"Officer (VP, General Counsel & Secr)","n_filings":1,"first_seen":"2013-07-02","last_seen":"2013-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578823","retrieved_at":"2026-08-26T10:23:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}